Frank J. Lagerwaard

Amsterdam, NH 1081HZ, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 16, 2026

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Journal: PloS one

Published: January 12, 2026

Recurrent hematological toxicity after second-line treatment in patients with glioblastoma: indication of a potential predisposition.

Recurrent hematological toxicity after second-line treatment in patients with glioblastoma: indication of a potential predisposition.

Journal: The oncologist

Published: July 26, 2025

Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial.

Systemic immunomodulation by irreversible electroporation versus stereotactic ablative body radiotherapy in locally advanced pancreatic cancer: the CROSSFIRE trial.

Journal: Journal for immunotherapy of cancer

Published: January 28, 2025

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.

MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial.

Journal: The lancet. Gastroenterology & hepatology

Published: December 11, 2023

Editorial: Radiation therapy using MRI-Linac - the right way to start: a guide for physicians and physicists.

Editorial: Radiation therapy using MRI-Linac - the right way to start: a guide for physicians and physicists.

Journal: Frontiers in oncology

Published: July 13, 2023

Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes.

Dual-center validation of using magnetic resonance imaging radiomics to predict stereotactic radiosurgery outcomes.

Journal: Neuro-oncology advances

Published: June 26, 2023

Predicting stereotactic radiosurgery outcomes with multi-observer qualitative appearance labelling versus MRI radiomics.

Predicting stereotactic radiosurgery outcomes with multi-observer qualitative appearance labelling versus MRI radiomics.

Journal: Scientific reports

Published: May 10, 2023

Ten years outcomes after SABR in central and ultracentral primary lung tumors.

Ten years outcomes after SABR in central and ultracentral primary lung tumors.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 12, 2023

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.

Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 28, 2023

ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.

ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 03, 2023

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort.

Journal: Frontiers in oncology

Published: January 23, 2023

Showing 1-12 of 90

Last Updated: 09/26/2026